RxDoctor Payments Data
★ My doctorsLook up a doctor →

David Kaufman

Pediatrics · Omaha, NENPI 1538156302

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 29.8% of the total.

$1,559in general payments, 2019–2025

Across 83 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$465
  • Tris Pharma Inc$323
  • Galderma Laboratories, L.p.$121
  • Sanofi-aventis U.S. LLC$90
  • Merck$69
  • Corium, LLC$58
  • plus $432 from 17 others

What the payments were for

  • Food & beverage$1,559100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Supernus Pharmaceuticals, Inc.26$465
Tris Pharma Inc17$323
Galderma Laboratories, L.p.1$121
Sanofi-aventis U.S. LLC4$90
Merck4$69
Corium, LLC3$58
Takeda Pharmaceuticals U.S.A., Inc.4$55
ARS Pharmaceuticals Operations, Inc.3$52
Ironshore Pharmaceuticals Inc.4$49
Pfizer2$34
Seqirus USA Inc1$32
Vertical Pharmaceuticals, LLC2$29
Kaleo, Inc.2$27
Sanofi Pasteur Inc.1$23
AstraZeneca1$21
Collegium Pharmaceutical, Inc.1$18
Kyowa Kirin, Inc.1$15
Kowa Pharmaceuticals America, Inc.1$15
Neos Therapeutics, LP1$13
GSK1$13
Phadia US Inc.1$12
Shire North American Group Inc1$12
Arbor Pharmaceuticals, Inc.1$11

How this compares

$1,559 in reported general payments places this provider in the 85th percentile of 308 pediatrics providers in Nebraska.

See all pediatrics providers in Nebraska →

Most prescribed under Part D

DrugClaimsCost to plans & patients
VascepaIcosapent Ethyl13$1,138
Guanfacine Hcl14$475
Omeprazole11$76

Paid to pharmacies, not to this prescriber.

Other pediatrics in Omaha

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →